Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Propofol Plus High-dose Alfentanil in Rapid Sequence Induction
NCT07730918Completed
- Sponsor
- Aoyang Hospital
- Start
- Aug 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Open-label trial of propofol injection (veterinary) and alfentanil in hemodynamic instability (4 arms), sponsored by Aoyang Hospital. Primary endpoints: Post-induction hypotension, Substantial heart rate decline and 1 more. Started Aug 2025; status: completed.
02
Drugs
propofol injection (veterinary)alfentanil
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT07730918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730918.